Renoprotective effects of 3 HMG reductase blockers in elderly patients with acute coronary syndrome undergoing revascularization through percutaneous coronary intervention

Documenti analoghi

• Acute esophageal necrosis masquerading acute coronary syndrome
  di: Ruhin Yuridullah
  Pubblicazione: (2020)
• Cost-effectiveness analysis of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome in Colombia
  di: Aurelio Mejía
  Pubblicazione: (2015)
• Clinical-functional changes of myocardium after percutaneous coronary interventions in patients with chronic heart failure
  di: Olga A. Efremova
  Pubblicazione: (2019)
• Prasugrel compared to clopidogrel in patients with acutecoronary syndrome undergoing percutenous coronaryintervention: a Spanish model-based cost-effectiveness analysis
  di: A. Davies
  Pubblicazione: (2013)
• Cardiorenal Medicine
  Pubblicazione: (2023)